首页>
外国专利>
Short-chain deoxyribonucleic acid or sustained-release microspheres containing short-chain ribonucleic acid and method for producing the same
Short-chain deoxyribonucleic acid or sustained-release microspheres containing short-chain ribonucleic acid and method for producing the same
展开▼
机译:含有短链核糖核酸的短链脱氧核糖核酸或缓释微球及其制备方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
In a sustained-release microsphere preparation comprising a short-chain deoxyribonucleic acid or a short-chain ribonucleic acid as an active ingredient, the sustained-release property is improved and a preparation effective for a long period of time is provided. An injectable or transmucosally administrable fine particle formulation in which short-chain deoxyribonucleic acid or short-chain ribonucleic acid is stably encapsulated and the expression of a specific protein involved in a disease can be suppressed over a long period of time, and a method for producing the same provide. In biodegradable polymers in sustained-release microsphere preparations containing short-chain deoxyribonucleic acid or short-chain ribonucleic acid, especially siRNA as active ingredients, especially sustained-release microspheres prepared via w1 / o / w2 emulsion It contains a basic substance having a positive charge such as arginine, polyethyleneimine, cell-penetrating peptide, poly-L-lysine, poly-L-ornithine.
展开▼
机译:在包含短链脱氧核糖核酸或短链核糖核酸作为有效成分的缓释微球制剂中,缓释性能得到改善,并且提供了长期有效的制剂。可以稳定地包封短链脱氧核糖核酸或短链核糖核酸并且可以长期抑制与疾病有关的特定蛋白质的表达的注射或经粘膜给药的微粒制剂及其制备方法同样提供。在包含短链脱氧核糖核酸或短链核糖核酸,特别是siRNA作为活性成分的缓释微球制剂的生物可降解聚合物中,特别是通过w1 / o / w2乳液制备的缓释微球。它包含带正电荷的碱性物质例如精氨酸,聚乙烯亚胺,穿透细胞的肽,聚-L-赖氨酸,聚-L-鸟氨酸。
展开▼